Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent Rajkumar

Showing results (441-450 of 566) with videos related to

Pageof 57
Sort By:
Leukemia|July 31, 2020
Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
European Journal of Haematology|March 8, 2020
c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myelomaAlessandra Di Bacco, Nizar J Bahlis, Nikhil C Munshi, et al.
American Journal of Hematology|December 29, 2018
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry methodSurbhi Sidana, Dragan Jevremovic, Rhett P Ketterling, et al.
Blood|October 22, 2017
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patientsHervé Avet-Loiseau, Nizar J Bahlis, Wee-Joo Chng, et al.
Blood|January 28, 2017
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early deathEli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
British Journal of Haematology|August 2, 2021
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemiaSaurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.
Mayo Clinic Proceedings|February 17, 2019
A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified TypingEli Muchtar, Morie A Gertz, Robert A Kyle, et al.
Leukemia|February 22, 2019
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myelomaGaurav Goyal, S Vincent Rajkumar, Martha Q Lacy, et al.
Leukemia|October 27, 2021
Mortality trends in multiple myeloma after the introduction of novel therapies in the United StatesMoritz Binder, Bharat Nandakumar, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working GroupMeletios A Dimopoulos, Evangelos Terpos, Asher Chanan-Khan, et al.
Pageof 57

Showing results (441-450 of 566) with videos related to

Sort By:
Pageof 57
Leukemia|July 31, 2020
Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
European Journal of Haematology|March 8, 2020
c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myelomaAlessandra Di Bacco, Nizar J Bahlis, Nikhil C Munshi, et al.
American Journal of Hematology|December 29, 2018
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry methodSurbhi Sidana, Dragan Jevremovic, Rhett P Ketterling, et al.
Blood|October 22, 2017
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patientsHervé Avet-Loiseau, Nizar J Bahlis, Wee-Joo Chng, et al.
Blood|January 28, 2017
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early deathEli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
British Journal of Haematology|August 2, 2021
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemiaSaurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.
Mayo Clinic Proceedings|February 17, 2019
A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified TypingEli Muchtar, Morie A Gertz, Robert A Kyle, et al.
Leukemia|February 22, 2019
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myelomaGaurav Goyal, S Vincent Rajkumar, Martha Q Lacy, et al.
Leukemia|October 27, 2021
Mortality trends in multiple myeloma after the introduction of novel therapies in the United StatesMoritz Binder, Bharat Nandakumar, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working GroupMeletios A Dimopoulos, Evangelos Terpos, Asher Chanan-Khan, et al.
Pageof 57